Ocular Therapeutix™ Reports Second Quarter 2017 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Ocular Therapeutix™ Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Ocular Therapeutix (OCUL) Misses Q2 EPS by 8c

August 8, 2017 5:37 PM EDT

Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.64), $0.08 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $438 thousand versus the consensus estimate of $490 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

... More